Bortezomib Injection 2mg
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
Bortezomib Injection 2mg is a cytotoxic anticancer medicine used in the treatment of certain blood cancers. It works by slowing or stopping the growth of cancer cells and is administered under strict hospital supervision as part of chemotherapy regimens.
Product Overview
Product Name: Bortezomib Injection 2mg
Generic Name: Bortezomib
Form: Lyophilized powder for injection (cytotoxic)
Strength: 2mg
Pack Size: Single vial
Manufactured By:
Used For: Multiple myeloma, mantle cell lymphoma (as prescribed by oncologist)
Prescription Required: Yes
Ingredients & How They Work
Bortezomib → a proteasome inhibitor that blocks the 26S proteasome, preventing cancer cells from breaking down damaged proteins. This leads to protein buildup inside cancer cells, triggering cell cycle arrest and apoptosis (cell death).
Key Benefits
- Used in treatment of multiple myeloma
- Helps slow progression of certain blood cancers
- Works in combination chemotherapy regimens
- Targets cancer cells specifically via proteasome inhibition
- Supports disease control under oncology supervision
How to Use
Administered only by a healthcare professional via subcutaneous or intravenous injection. Dosage and schedule depend on cancer type and treatment protocol. Never self-administer.
Side Effects & Precautions
Common side effects include fatigue, nausea, vomiting, diarrhea, low blood cell counts, peripheral neuropathy (tingling or numbness), and fever. Serious risks include infections, nerve damage, and blood disorders. Requires close medical monitoring.
Storage Instructions
Store as directed (usually refrigerated or controlled temperature depending on formulation). Protect from light and moisture. Keep out of reach of children.